Skip to main navigation Skip to search Skip to main content

Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5-component Acellular Pertussis Vaccine in Infants and Toddlers

Project: Research

Project Details

StatusFinished
Effective start/end date12/1/05 → 11/30/10

Funding

  • Sanofi Pasteur Incorporated: $89,906.71